Based on the results of the TCGA cohort, which showed that patients with higher BBB scores were more likely to have more malignant characteristics, such as wild-type IDH status, 1p/19q noncodeletion and TERT mRNA expression [33], we could conclude that the BBB score would increase with the malignant progression of glioma. This evidence concerns the gene TERT and glioma.